42 related articles for article (PubMed ID: 34580877)
1. Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes.
Grosser B; Glückstein MI; Dhillon C; Schiele S; Dintner S; VanSchoiack A; Kroeppler D; Martin B; Probst A; Vlasenko D; Schenkirsch G; Märkl B
J Pathol; 2022 Jan; 256(1):71-82. PubMed ID: 34580877
[TBL] [Abstract][Full Text] [Related]
2. Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response.
Grosser B; Heyer CM; Austgen J; Sipos E; Reitsam NG; Hauser A; VanSchoiack A; Kroeppler D; Vlasenko D; Probst A; Novotny A; Weichert W; Keller G; Schlesner M; Märkl B
Gastric Cancer; 2024 Jan; 27(1):72-85. PubMed ID: 37874427
[TBL] [Abstract][Full Text] [Related]
3. Advancing gastric cancer precision medicine with novel genomic screens
Halmai NB; Carvajal-Carmona LG
J Pathol; 2023 Apr; 259(4):359-361. PubMed ID: 36541926
[TBL] [Abstract][Full Text] [Related]
4. Pseudobudding: ruptured glands do not represent true tumor buds.
Haddad TS; van den Dobbelsteen L; Öztürk SK; Geene R; Nijman IJ; Verrijp K; Jamieson NB; Wood C; van Vliet S; Reuvers L; Achouiti S; Rutgers N; Brouwer N; Simmer F; Zlobec I; Lugli A; Nagtegaal ID
J Pathol; 2023 Sep; 261(1):19-27. PubMed ID: 37403270
[TBL] [Abstract][Full Text] [Related]
5. Unselective Measurement of Tumor-to-Stroma Proportion in Colon Cancer at the Invasion Front-An Elusive Prognostic Factor: Original Patient Data and Review of the Literature.
Fekete Z; Ignat P; Resiga AC; Todor N; Muntean AS; Resiga L; Curcean S; Lazar G; Gherman A; Eniu D
Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667481
[TBL] [Abstract][Full Text] [Related]
6. Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours.
Rico K; Duan S; Pandey RL; Chen Y; Chakrabarti JT; Starr J; Zavros Y; Else T; Katona BW; Metz DC; Merchant JL
BMJ Open Gastroenterol; 2021 Nov; 8(1):. PubMed ID: 34750164
[TBL] [Abstract][Full Text] [Related]
7. Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a Retrospective Study.
Martin B; Grosser B; Kempkens L; Miller S; Bauer S; Dhillon C; Banner BM; Brendel EM; Sipos É; Vlasenko D; Schenkirsch G; Schiele S; Müller G; Märkl B
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638364
[TBL] [Abstract][Full Text] [Related]
8. Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study.
Ulase D; Behrens HM; Röcken C
Virchows Arch; 2024 May; ():. PubMed ID: 38748262
[TBL] [Abstract][Full Text] [Related]
9. Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.
Reitsam NG; Grosser B; Enke JS; Mueller W; Westwood A; West NP; Quirke P; Märkl B; Grabsch HI
Transl Oncol; 2024 Jun; 44():101913. PubMed ID: 38593584
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.
Ren F; Fei Q; Qiu K; Zhang Y; Zhang H; Sun L
J Exp Clin Cancer Res; 2024 Apr; 43(1):96. PubMed ID: 38561776
[TBL] [Abstract][Full Text] [Related]
11. Applications of single‑cell omics and spatial transcriptomics technologies in gastric cancer (Review).
Ren L; Huang D; Liu H; Ning L; Cai P; Yu X; Zhang Y; Luo N; Lin H; Su J; Zhang Y
Oncol Lett; 2024 Apr; 27(4):152. PubMed ID: 38406595
[TBL] [Abstract][Full Text] [Related]
12. SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.
Enke JS; Groß M; Grosser B; Sipos E; Steinestel J; Löhr P; Waidhauser J; Lapa C; Märkl B; Reitsam NG
BMC Cancer; 2024 Jan; 24(1):65. PubMed ID: 38216952
[TBL] [Abstract][Full Text] [Related]
13. Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
Grosser B; Emmerson J; Reitsam NG; Cunningham D; Nankivell M; Langley RE; Allum WH; Trepel M; Märkl B; Grabsch HI
Br J Cancer; 2024 Feb; 130(3):457-466. PubMed ID: 38123705
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of microRNA-21 on differentially expressed hub genes in gastric cancer based on systems biology.
Kalajahi HG; Yari A; Amini M; Catal T; Ahmadpour Youshanlui M; Pourbagherian O; Zhmurov CS; Mokhtarzadeh A
Sci Rep; 2023 Dec; 13(1):21906. PubMed ID: 38081950
[TBL] [Abstract][Full Text] [Related]
15. Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology.
Reitsam NG; Grozdanov V; Löffler CML; Muti HS; Grosser B; Kather JN; Märkl B
Cancer Gene Ther; 2024 Feb; 31(2):207-216. PubMed ID: 37990064
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
